CardiovascularORALGeneric
NYSTATIN
NYSTATIN
Standard Dose
500,000 UNITS
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NYSTATIN is listed in Drugs@FDA under application 062838 (ANDA).
Marketing status: Discontinued Active ingredient NYSTATIN Form and strength TABLET;ORAL - 500,000 UNITS Sponsor SUN PHARM INDUSTRIES Submission history Latest submission status date: 2002-06-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview NYSTATIN is listed in Drugs@FDA under application 062838 (ANDA). Marketing status: Discontinued Active ingredient NYSTATIN Form and strength TABLET;ORAL - 500,000 UNITS Sponsor SUN PHARM INDUSTRIES Submission history Latest submission status date: 2002-06-28 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.